FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3146078615> ?p ?o ?g. }

• W3146078615 endingPage "e11059" @default.
• W3146078615 startingPage "e11059" @default.
• W3146078615 abstract "Vancomycin-resistant enterococci (VRE) are a serious public health threat and a leading cause of healthcare-associated infections. Bacterial resistance to antibiotics recommended for the treatment of enterococcal infections complicates the management of these infections. Hence, there is a critical need for the discovery of new anti-VRE agents. We previously reported carbonic anhydrase inhibitors (CAIs) as new potent VRE inhibitors. In the present study, the activity of the CAI, dorzolamide was evaluated against VRE both in vitro and in vivo. Dorzolamide exhibited potent activity against a panel of clinical VRE isolates, with minimum inhibitory concentration (MIC) values ranging from 1 µg/mL to 8 µg/mL. A killing kinetics experiment determined that dorzolamide exhibited a bacteriostatic effect against VRE, which was similar to the drug of choice (linezolid). Dorzolamide interacted synergistically with gentamicin against four strains of VRE, and exhibited an additive interaction with gentamicin against six VRE strains, reducing gentamicin’s MIC by several folds. Moreover, dorzolamide outperformed linezolid in an in vivo VRE colonization reduction mouse model. Dorzolamide significantly reduced the VRE burden in fecal samples of mice by 2.9-log 10 (99.9%) and 3.86-log 10 (99.99%) after 3 and 5 days of treatment, respectively. Furthermore, dorzolamide reduced the VRE count in the cecal (1.74-log 10 (98.2%) reduction) and ileal contents (1.5-log 10 (96.3%)) of mice, which was superior to linezolid. Collectively, these results indicate that dorzolamide represents a promising treatment option that warrants consideration as a supplement to current therapeutics used for VRE infections." @default.
• W3146078615 created "2021-04-13" @default.
• W3146078615 creator A5026553668 @default.
• W3146078615 creator A5054207395 @default.
• W3146078615 creator A5062624986 @default.
• W3146078615 creator A5068814682 @default.
• W3146078615 date "2021-03-30" @default.
• W3146078615 modified "2023-10-12" @default.
• W3146078615 title "In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci" @default.
• W3146078615 cites W1783811381 @default.
• W3146078615 cites W1904634031 @default.
• W3146078615 cites W1905008412 @default.
• W3146078615 cites W1958799813 @default.
• W3146078615 cites W1975867520 @default.
• W3146078615 cites W1979065420 @default.
• W3146078615 cites W1979573684 @default.
• W3146078615 cites W1980519563 @default.
• W3146078615 cites W1990152860 @default.
• W3146078615 cites W1998555394 @default.
• W3146078615 cites W2001792721 @default.
• W3146078615 cites W2002584091 @default.
• W3146078615 cites W2025322665 @default.
• W3146078615 cites W2049503038 @default.
• W3146078615 cites W2078291699 @default.
• W3146078615 cites W2082395198 @default.
• W3146078615 cites W2082720590 @default.
• W3146078615 cites W2084266616 @default.
• W3146078615 cites W2103599303 @default.
• W3146078615 cites W2104249477 @default.
• W3146078615 cites W2105408410 @default.
• W3146078615 cites W2111266377 @default.
• W3146078615 cites W2123747293 @default.
• W3146078615 cites W2138023605 @default.
• W3146078615 cites W2144631364 @default.
• W3146078615 cites W2156781074 @default.
• W3146078615 cites W2162767822 @default.
• W3146078615 cites W2166052208 @default.
• W3146078615 cites W2166356134 @default.
• W3146078615 cites W2175741618 @default.
• W3146078615 cites W2217257743 @default.
• W3146078615 cites W2258927068 @default.
• W3146078615 cites W2471456962 @default.
• W3146078615 cites W2522202304 @default.
• W3146078615 cites W2591346198 @default.
• W3146078615 cites W2594120940 @default.
• W3146078615 cites W2755282553 @default.
• W3146078615 cites W2791045633 @default.
• W3146078615 cites W2805025568 @default.
• W3146078615 cites W2806824088 @default.
• W3146078615 cites W2893179729 @default.
• W3146078615 cites W2894528081 @default.
• W3146078615 cites W2900331994 @default.
• W3146078615 cites W2914827026 @default.
• W3146078615 cites W2949066452 @default.
• W3146078615 cites W2973974748 @default.
• W3146078615 cites W2981709337 @default.
• W3146078615 cites W3004227146 @default.
• W3146078615 cites W3013496878 @default.
• W3146078615 cites W3014161470 @default.
• W3146078615 cites W3015835414 @default.
• W3146078615 cites W3046074753 @default.
• W3146078615 cites W3079552435 @default.
• W3146078615 cites W4210969014 @default.
• W3146078615 cites W4323282442 @default.
• W3146078615 cites W94455333 @default.
• W3146078615 doi "https://doi.org/10.7717/peerj.11059" @default.
• W3146078615 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8018244" @default.
• W3146078615 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33850651" @default.
• W3146078615 hasPublicationYear "2021" @default.
• W3146078615 type Work @default.
• W3146078615 sameAs 3146078615 @default.
• W3146078615 citedByCount "24" @default.
• W3146078615 countsByYear W31460786152021 @default.
• W3146078615 countsByYear W31460786152022 @default.
• W3146078615 countsByYear W31460786152023 @default.
• W3146078615 crossrefType "journal-article" @default.
• W3146078615 hasAuthorship W3146078615A5026553668 @default.
• W3146078615 hasAuthorship W3146078615A5054207395 @default.
• W3146078615 hasAuthorship W3146078615A5062624986 @default.
• W3146078615 hasAuthorship W3146078615A5068814682 @default.
• W3146078615 hasBestOaLocation W31460786151 @default.
• W3146078615 hasConcept C141071460 @default.
• W3146078615 hasConcept C150903083 @default.
• W3146078615 hasConcept C176947019 @default.
• W3146078615 hasConcept C181199279 @default.
• W3146078615 hasConcept C185592680 @default.
• W3146078615 hasConcept C207001950 @default.
• W3146078615 hasConcept C2775832221 @default.
• W3146078615 hasConcept C2775914622 @default.
• W3146078615 hasConcept C2776727336 @default.
• W3146078615 hasConcept C2778073030 @default.
• W3146078615 hasConcept C2778980435 @default.
• W3146078615 hasConcept C2779489039 @default.
• W3146078615 hasConcept C2781092963 @default.
• W3146078615 hasConcept C2781414143 @default.
• W3146078615 hasConcept C501593827 @default.
• W3146078615 hasConcept C523546767 @default.
• W3146078615 hasConcept C54355233 @default.

• next